[Chronic ischemic heart failure. Revascularization improves survival among patients with hibernating myocardium]

Paw Chr Holdgaard1, Søren Steen Nielsen, Henrik Wiggers

  • 1Arhus Universitetshospital, Skejby, Afdelingen for Klinisk Fysiologi, Arhus N. paw@dadlnet.dk

Ugeskrift for Laeger
|December 15, 2007
PubMed

Insights

Patients with hibernating myocardium (HIB) who received revascularization showed improved survival rates. Untreated HIB significantly increased the risk of sudden cardiac death, highlighting the importance of nuclear imaging for treatment decisions.

Area of Science:

  • Cardiology
  • Nuclear Medicine
  • Medical Imaging

Background:

  • Ischemic heart failure patients with hibernating myocardium (HIB) can benefit from revascularization.
  • Nuclear imaging techniques are crucial for identifying these patients.
  • This study evaluates imaging results in relation to treatment and mortality.

Purpose of the Study:

  • To assess the outcomes of nuclear imaging procedures in patients evaluated for HIB.
  • To correlate imaging findings with treatment choices and causes of death.
  • To determine the prognostic value of identifying hibernating myocardium.

Main Methods:

  • Retrospective analysis of 51 patients over 2 years.
  • Utilized myocardial perfusion imaging (99mTc-sestamibi) and glucose metabolism imaging (18F-FDG PET).
  • Reviewed medical records and death certificates.

Main Results:

  • Included 50 patients; revascularized HIB patients had significantly lower 1-year mortality (6% vs. 33%, p=0.004).
  • Patients with HIB who did not undergo revascularization faced a higher risk of sudden death (p=0.003).
  • Nuclear imaging effectively identified patients with hibernating myocardium.

Conclusions:

  • Nuclear imaging is valuable for selecting heart failure patients for revascularization.
  • Revascularization improves survival in patients with hibernating myocardium.
  • Further prospective studies are needed to mitigate potential selection bias from retrospective analyses.
Abstract

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...